Kalyan Mantripragada, MD, MPH

Medical Oncologist

Gastrointestinal Malignancies

"Our family feels so blessed to have Dr. Matripragada as my dad's oncologist. He is caring and really wants the best quality of life as well as overall health for my dad. We would highly recommend him."

Dr. Mantripragada specializes in gastrointestinal malignancies and hematologic disorders. He joined Ironwood Cancer & Research Centers in March 2018.

He earned his medical degree from Rangaraya Medical College. He has a Master of Public Health from Western Kentucky University. He completed his Internal Medicine Residency at the Bronx Lebanon Hospital Center and his Hematology & Medical Oncology Fellowship at Warren Alpert Medical School of Brown University.

He is a Fellow of the American College of Physicians a member of the American College of Physicians, American Society of Clinical Oncology, and American Society of Hematology.

During his time at Brown University from 2011 to 2018, his primary focus of patient care and research was in gastrointestinal malignancies. He played crucial roles as clinical researcher and statistician for the Brown University Oncology Group, and developed various investigator-initiated protocols, published and presented his research findings in high impact journals and national meetings. He published some of the most extensive experiences in post-surgical therapy for gall bladder cancer and next generation sequencing and targeted therapy in gastrointestinal cancers. He served as an attending in its department of gastrointestinal malignancies.

He brings his extensive experience in the field of gastrointestinal malignancies to serve the community through Ironwood.

Dr. Mantripragada is actively involved in the education of medical students and residents from Creighton University School of Medicine and serves as a Clinical Assistant Professor in Hematology and Medical Oncology.

Present Title & Subspecialties

Title

Medical Oncology & Hematology

Subspecialties

Gastrointestinal Malignancies

Education & Training

Medical School

Rangaraya Medical College—NTR University of Health Sciences

Fellowships

Warren Alpert Medical School of Brown University, Hematology & Medical Oncology

Cancers Treated

Anal Cancer

Cholangiocarcinoma (Bile Duct Cancer)

Colon Cancer

Esophageal Cancer

Gallbladder Cancer

Gastrointestinal Stromal Tumor (GIST)

Liver Cancer

Neuroendocrine Tumor

Pancreatic Cancer

Rectal Cancer

Small Bowel Cancer

Stomach Cancer

Certifications & Professional Memberships

Board Certified Medical Oncology & Hematology
Clinical Assistant Professor in Hematology and Medical Oncology, Creighton University
Reviewer -Annals of Internal Medicine (2013)
Editorial Board – Indian Journal of Case Reports (2013
Reviewer -Journal of General Internal Medicine (2013)

Publications

Khurshid, H., Dipetrillo, T., Ng, T., Mantripragada, K., Birnbaum, A., Berz, D., … & Safran, H. (2012). Frontiers in Oncology A phase I study of dasatinib with concurrent chemoradiation for stage III non-small cell lung cancer.

Paclitaxel poliglumex, temozolomide, and radiation for newly diagnosed high-grade glioma: a Brown University Oncology Group Study.Jeyapalan S, Boxerman J, Donahue J, Goldman M, Kinsella T, Dipetrillo T, Evans D, Elinzano H, Constantinou M, Stopa E, Puthawala Y, Cielo D, Santaniello A, Oyelese A, Mantripragada K, Rosati K, Isdale D, Safran H; Brown University Oncology Group Study.Am J Clin Oncol. 2014 Oct;37(5):444-9. doi: 10.1097/COC.0b013e31827de92b.PMID: 23388562

Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study
Howard Safran 1, Kevin P Charpentier, Andreas Kaubisch, Kalyan Mantripragada, Gregory Dubel, Kimberly Perez, Katherine Faricy-Anderson, Thomas Miner, Yoko Eng, Joel Victor, Angela Plette, Joseph Espat, Pamela Bakalarski, Patti Wingate, David Berz, Denise Luppe, Diane Martel, Kayla Rosati, Santiago Aparo PMID: 23648434 DOI: 10.1097/COC.0b013e3182868c66

Mantripragada, K., & Khurshid, H. (2013). Targeting genomic alterations in squamous cell lung cancer. Frontiers in oncology, 3.

Mantripragada, K., Reagan, J. L., Quesenberry, P. J., & Fast, L. D. (2014). Advances in cellular therapy for the treatment of leukemia. Discovery medicine , 17(91), 15-24.

Mantripragada, K., & Birnbaum, A. (2015). Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and Pancreas. Cureus 7(12): e403.

Reagan, J. L., Fast, L. D., Nevola, M., Mantripragada, K., Mulder, A., Claas, F. H. J., … & Quesenberry, M. I. (2015). Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia. Blood cancer journal, 5(12), e371.

Elinzano, , Glantz, M., Mrugala, M., Kesari, S., Piccioni, D. E., Kim, L., Pan, E., Shakeeb, Y., Coyle, T., Kinsella, T., Evans, D., Mantripragada, K., … & Evans, D. (2015). PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244. American journal of clinical oncology.

Mantripragada, C., Olszewski, A. J., Schumacher, A., Perez, K., Birnbaum, A., Reagan, J. L., … & Safran, H. (2016). ReCAP: Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute–Designated Cancer Program.

Mantripragada, C., Fircanis, R. S., Reagan, J. L., & LeGolvan, M. (2016). Acquired Syphilis With Anemia and Leukoerythroblastic Reaction: A Case Report. Annals of internal medicine.

Mantripragada, C., & Safran, H. (2016). Optimizing initial chemotherapy for metastatic pancreatic cancer. Future Oncology.

Olszewski, J., Mantripragada, K. C., Castillo, J. (2016). Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma. Journal of the National Comprehensive Cancer Network . 14:1121-29.

Mantripragada, C., Hamid, F., Shafquat, H., Olszewski, A. J. (2017). Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base. Journal of the National Cancer Institute . 109 (2): djw202.

Mantripragada & Quesenberry, P. J. (2017). Polarization of neutrophil granules — A characteristic of inflammatory states. Blood Cells, Molecules, and Diseases, Available online 25 September 2017, ISSN 1079-9796,

ABSTRACTS AND POSTER PRESENTATIONS

Chun, K., Chamarthy, M., Feng, J., Tokayer, A., Behin, D., Mantripragada, K., … & Freeman, L. (2008). Various patterns of gastric emptying: A comparison of half time with four-hour retention. Journal of Nuclear Medicine, 49(supplement 1), 39P-39P.
Chamarthy, M., Chun, K., Tokayer, A., Mantripragada, K., Feng, J., Goldfarb, R., & Freeman, L. (2008). Role of multiple end point testing to detect various patterns of gastric emptying disorders.
Safran, H., Charpentier, K., Kaubisch, A., Dubel, G., Perez, K., Faricy-Anderson, K., Miner, T., Mantripragada, K.. … & Isdale, D. (2012, June). Lenalidomide for Second-Line Treatment of Advanced Hepatocellular Cancer: A Brown University Oncology Group Phase II Study. Journal of Clinical Oncology, (Vol. 30, No. 15_suppl, p. 2318).
Safran, H., Charpentier, K., Perez, K., Mantripragada, K., Austin, T. C., Nadeem, O., … & Mitchell, K. (2014, January). FOLFOX and nab-paclitaxel (nab-P) for advanced pancreatic cancer: A phase I study. Journal of Clinical Oncology, (Vol. 32, No. 3_suppl, p. 258).
Safran, H., Perez, K., Charpentier, K., Austin, T. C., Mantripragada, K. C., Bishop, K. D., … & Martel, D. (2014, May). Nab-paclitaxel (nab-P) combined with FOLFOX for advanced pancreatic cancer: A phase I study. Journal of Clinical Oncology, (Vol. 32, No. 15_suppl, p. 4123).